Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Verena Andrea Katzke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6509-6555; OpenAlex author ID A5071536718. Sources: OpenAlex.

Their work

Papers
47 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
130
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 3 papers · 2017: 4 papers · 2018: 4 papers · 2019: 5 papers · 2020: 7 papers · 2021: 2 papers · 2022: 4 papers · 2023: 3 papers · 2024: 1 paper · 2025: 5 papers · 2026: 6 papers

Papers 47

  1. Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort. Co-author DOI 10.1002/ijc.70581↗
  2. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  3. The Association of Diabetes-Related Dietary Patterns with Pancreatic Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Co-author DOI 10.1016/j.tjnut.2026.101755↗
  4. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  5. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  6. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  7. Factors influencing the diagnostic basis in pancreatic cancer. A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Last author DOI 10.1016/j.ctarc.2025.101009↗
  8. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  9. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  10. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  11. Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer an… Co-author DOI 10.3390/cancers17142275↗
  12. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  13. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  14. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  15. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  16. Inflammatory potential of diet and pancreatic cancer risk in the EPIC study. Co-author DOI 10.1007/s00394-022-02809-y↗
  17. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  18. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. Co-author DOI 10.1038/s41598-022-22973-9↗
  19. Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Co-author DOI 10.1093/ije/dyab115↗
  20. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. Co-author DOI 10.1136/jmedgenet-2020-106961↗
  21. Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures. Co-author DOI 10.1158/1055-9965.epi-21-0169↗
  22. Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.32415↗
  23. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  24. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Co-author DOI 10.1007/s10654-019-00559-6↗
  25. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  26. Mitochondrial DNA Copy-Number Variation and Pancreatic Cancer Risk in the Prospective EPIC Cohort. First author DOI 10.1158/1055-9965.epi-19-0868↗
  27. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  28. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  29. Dietary folate intake and pancreatic cancer risk: Results from the European prospective investigation into cancer and nutrition. Co-author DOI 10.1002/ijc.31830↗
  30. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. First author DOI 10.1002/ijc.31900↗
  31. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Co-author DOI 10.1002/ijc.31928↗
  32. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32127↗
  33. Socioeconomic Effect of Education on Pancreatic Cancer Risk in Western Europe: An Update on the EPIC Cohorts Study. Co-author DOI 10.1158/1055-9965.epi-18-1153↗
  34. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Co-author DOI 10.1002/ijc.31047↗
  35. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Co-author DOI 10.1002/ijc.31146↗
  36. Lifetime and baseline alcohol intakes and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition study. Co-author DOI 10.1002/ijc.31367↗
  37. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort. Co-author DOI 10.1002/ijc.31797↗
  38. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition… Co-author DOI 10.1002/ijc.30590↗
  39. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Co-author DOI 10.1002/ijc.30790↗
  40. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Co-author DOI 10.1038/bjc.2017.14↗
  41. Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium. Co-author DOI 10.1158/1055-9965.epi-17-0075↗
  42. Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.30190↗
  43. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Co-author DOI 10.18632/oncotarget.10935↗
  44. Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Co-author DOI 10.3945/ajcn.116.130963↗
  45. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  46. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  47. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗

Closest collaborators

The 25 strongest of 130 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marta Crous‐Bou · 6 shared papers, 2021–2026 · strength 0.97
  2. Rudolf Kaaks · 13 shared papers, 2013–2026 · strength 0.94
  3. Vinciane Rebours · 12 shared papers, 2017–2026 · strength 0.90
  4. Federico Canzian · 9 shared papers, 2014–2026 · strength 0.83
  5. Malin Sund · 13 shared papers, 2013–2025 · strength 0.78
  6. Eric J. Duell · 16 shared papers, 2013–2020 · strength 0.76
  7. Dagfinn Aune · 8 shared papers, 2017–2026 · strength 0.67
  8. Daniele Campa · 6 shared papers, 2014–2026 · strength 0.61
  9. H. Bas Bueno-de-Mesquita · 13 shared papers, 2013–2020 · strength 0.56
  10. Pietro Ferrari · 7 shared papers, 2013–2025 · strength 0.56
  11. María‐Dolores Chirlaque · 6 shared papers, 2017–2025 · strength 0.54
  12. Esther Molina‐Montes · 9 shared papers, 2013–2025 · strength 0.54
  13. Elio Ríboli · 12 shared papers, 2013–2020 · strength 0.53
  14. Bas H. Bueno-de-Mesquita · 6 shared papers, 2019–2022 · strength 0.49
  15. Paolo Vineis · 8 shared papers, 2013–2025 · strength 0.46
  16. Guri Skeie · 9 shared papers, 2013–2020 · strength 0.40
  17. Manuel Gentiluomo · 3 shared papers, 2020–2025 · strength 0.33
  18. Gabriele Capurso · 3 shared papers, 2017–2025 · strength 0.31
  19. Lívia Archibugi · 2 shared papers, 2022–2025 · strength 0.26
  20. Giulia Peduzzi · 2 shared papers, 2022–2025 · strength 0.26
  21. Sofia Christakoudi · 2 shared papers, 2021–2025 · strength 0.25
  22. Sandra Milena Colorado-Yohar · 2 shared papers, 2020–2025 · strength 0.25
  23. Sabine Naudin · 4 shared papers, 2018–2020 · strength 0.25
  24. Weimin Ye · 7 shared papers, 2013–2018 · strength 0.24
  25. John P. Neoptolemos · 3 shared papers, 2017–2022 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.